Jupiter, Fla., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Caring Brands Inc. (Nasdaq: CABR) today announced that it has entered into an exclusive worldwide license agreement with Itonis Inc. to manufacture, market, and distribute Emesyl, Itonis’s over-the-counter (OTC) nausea relief product. The agreement provides Caring Brands with full rights to commercialize Emesyl and to oversee all manufacturing activities associated with the product. Under the terms of the agreement, Caring Brands will assume responsibility fo ...

As filed with the Securities and Exchange Commission on October 10, 2025. Registration No. 333-289767 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 3 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CARING BRANDS, INC. (Primary Standard Industrial Classification Code Number) Nevada 2844 99-4103908 (I.R.S. Employer Identification Number) 130 S Indian River Drive, Suite 202 pbm# 1232, Fort Pierce, FL 34950 Tel: (561) 896-7616 (Address, including zip c ...

As filed with the Securities and Exchange Commission on September 19, 2025. Registration No. 333-289767 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CARING BRANDS, INC. (Exact Name of Registrant as Specified in its Charter) (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) Nevada 2844 99-4103908 (I.R.S. Employer Identification Nu ...

As filed with the Securities and Exchange Commission on September 08, 2025. Registration No. 333-289767 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CARING BRANDS, INC. (Exact Name of Registrant as Specified in its Charter) (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) Nevada 2844 99-4103908 (I.R.S. Employer Identification Nu ...

As filed with the Securities and Exchange Commission on August 21, 2025. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CARING BRANDS, INC. (Exact Name of Registrant as Specified in its Charter) (State or Other Jurisdiction of Incorporation or Organization) Nevada 2844 99-4103908 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 130 S Indian River Dri ...

As filed with the Securities and Exchange Commission on April 7, 2025. Registration No. 333-285964 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 To FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CARING BRANDS, INC. (Exact Name of Registrant as Specified in its Charter) (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) Nevada 2844 99-4103908 (I.R.S. Employer Identification Number) ...

As filed with the Securities and Exchange Commission on March 20, 2025. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CARING BRANDS, INC. Nevada 2844 99-4103908 (I.R.S. Employer Identification Number) 1061 E. Indiantown Rd Suite 110, Jupiter, FL 33477 Tel: (561) 896-7616 (Address, including zip code, and telephone number, including area code, of Registrant's principal executive offices) Glynn Wil ...

Registration No. 333-269794 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 (Amendment No. 3) FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Jupiter Wellness, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) As filed with the Securities and Exchange Commission on June 22, 2023 (Primary Standard Industrial Classification Code Number) 2844 82-2455880 (I.R.S. Employer Identification Number) 1061 E. Indi ...

As filed with the Securities and Exchange Commission on June 6, 2023 Registration No. 333-269794 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 (Amendment No. 2) FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Jupiter Wellness, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) (Primary Standard Industrial Classification Code Number) 2844 82-2455880 (I.R.S. Employer Identification Number) 1061 E. India ...

股份与发售 - 出售股东将出售多达8,631,574股普通股，含3年和5年认股权证对应的股份[9] - 截至2023年5月5日，公司有26,654,675股流通在外普通股[11] - 截至2023年5月10日，公司普通股在纳斯达克最后报告销售价为每股4.15美元[11] - 此次发售股份含3年和5年认股权证转换及行使的共8,631,574股[28] - 认股权证行使后公司将获约8631574美元[43] - 发售完成后普通股将达35286249股[43] 财务业绩 - 2023年第一季度收入为1121676美元，2022年同期为721629美元[108] - 2022年全年收入为6196743美元，2021年为2876273美元[108] - 2023年3月31日止三个月净亏损1308174美元，2022年同期为2919775美元[181] - 2022年全年净亏损15223028美元，2021年全年净利润28100245美元[181] - 2023年3月31日止三个月基本和摊薄每股亏损均为0.05美元，2022年同期为0.13美元[181] - 2022年全年基本和摊薄每股亏损均为0.69美元，2021年全年为1.69美元[181] - 2022年全年销售额为6196743美元，2021年为2876273美元[195] - 2022年全年销售成本为5170386美元，2021年为2340788美元[195] - 2022年全年毛利润为1026357美元，2021年为535485美元[195] - 2022年全年总费用为16249385美元，2021年为28635730美元[195] - 2022年全年营销费用为84689美元，2021年为522893美元[198][199] - 2022年全年基于股份的薪酬为4357372美元，2021年为9387963美元[198][199] 合作与授权 - 公司与年营收26亿美元的大正达成协议许可JW - 700，大正计划2024年将其商业化[39] - 公司在印度与Cosmofix Technovation Pvt Ltd和Sanpellegrino Cosmetics签署协议，授权使用JW - 700和Photocil产品[165] 风险因素 - 会计师对公司持续经营能力存疑[41] - 若无法跟上技术变革，产品可能过时[47] - 竞争可能导致公司失去市场份额和收入[48] - 政府监管不利变化可能严重损害公司业务和经营成果[50] - 现有或可能的CBD产品法规可能影响公司产品销售能力[52] - 法律变化可能使含CBD产品被视为非法，影响公司业务计划[64][65] - 公司从合法州购买大麻CBD，法律变化可能需寻找新供应商[67] - 公司产品含CBD的销售受州数量限制，法律变化可能影响收入[68] - 公司进入CBD行业后可能难获得所需保险，面临额外风险和财务责任[69] - 产品或成分的负面宣传可能影响销售和收入，阻碍融资和吸引合作伙伴[70] - 公司产品商业化需获监管批准，临床试验可能遇困难，导致批准延迟或无法获得[72][74] - 公司在监管申报方面经验有限，申报延迟或不利发展可能影响财务状况[78][79] - 产品候选药物若出现严重副作用，可能放弃或限制开发，临床暂停或终止会影响商业前景和收入[80][81] 其他信息 - 公司采用截至每年12月31日的12个月财政年度[25] - 公司普通股每股面值0.001美元[28] - 公司是一家非加速申报公司、较小报告公司和新兴成长公司[4] - 2023年1月23日公司完成了私募股权投资（PIPE Offering）[9] - 公司将承担注册普通股的所有费用和开支[10] - 公司计划将认股权证行使所得款项用于一般公司和营运资金用途[152] - 公司计划在可预见的未来保留所有收益用于运营，从未支付现金股息，也不预期支付[159] - 2022年12月31日和2021年12月31日递延税项资产分别约为6714609美元和4865890美元，均已被全额估值备抵[187] - 2023年3月31日止三个月、2022年和2021年全年研发费用分别为33148美元、562117美元和1079362美元[188] - 2023年1月19日，公司签订证券购买协议，发行8,631,574份普通股认股权证，行使价格为1美元/股[145] - 认股权证持有人的转换比例不得超过4.99%，特殊情况下可放弃该限制，但最高不得超过9.99%[146] - 公司高管和董事持有约34%的流通有投票权证券，对选举和投票有重大影响[136] - 公司普通股市场价格低于5美元/股，若被列为“低价股”，交易活动可能受不利影响[141]